Clinical Trial Update: A Phase III Randomized Controlled Trial Evaluating the Efficacy and Safety of Tofacitinib Combined With Imatinib in Patients With Moderate-to-Severe Palmoplantar Pustulosis [Phase 3]

View source ↗

Summary

A Phase III randomized trial evaluating the efficacy and safety of combining tofacitinib with imatinib for moderate-to-severe palmoplantar pustulosis; currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmoplantar Pustulosis

Drugs mentioned

• Gleevec (Imatinib)
• XELJANZ (tofacitinib)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Palmoplantar Pustulosis (PPP) | Phase 3 | Status: NOT_YET_RECRUITING